pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·7h ago·2 min read
save

STAT+: Are AI scribes useful tools in medical education, or a crutch that imperils learning?

Educators want future physicians to be fluent in AI scribes, but they worry what off-loading clinical notes to AI could do to learning.

Aug 3, 2026·read at STAT ↗

STAT PlusHealth tech Are AI scribes useful tools in medical education, or a crutch that imperils learning? Schools, health systems restrict access for trainees, as they await better research Manage alerts for this article Email this article Share this article By Lauren ChanAug. 3, 2026 AAAS Mass Media Science & Engineering Fellow Lauren Chan[email protected]Lauren writes about healthcare AI data interoperability, the science behind public health recommendations, and pharmaceutical advances in the rare disease space.

Hospitals have been quick to adopt artificial intelligence tools for automating note-taking during patient visits, saying they help lower physician burnout and increase revenues. Medical schools, though, are facing a vexing quandary over AI scribes. As much as educators want future physicians to be well-versed in the technology, they worry that letting students off-load the struggle of thinking through differential diagnoses to AI could do irreparable harm during the formative years of their medical training.Advertisement “The process of deliberately crafting the note forces us to use our brains to really wrestle with what’s happening,” said Jaideep Talwalkar, associate dean of educational technology and innovation at Yale School of Medicine.

“There’s an importance in doing that with great repetition.” STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+. Already have an account?

Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+.

Subscribe Log In Artificial intelligence, education, health tech, STAT+ Submit a correction requestReprints Lauren Chan AAAS Mass Media Science & Engineering Fellow Lauren writes about healthcare AI data interoperability, the science behind public health recommendations, and pharmaceutical advances in the rare disease space. Newsletter Tech is transforming health care and life sciences. Our original reporting is here to keep you ahead of the curve.

Recommended Health August 3, 2026 Heart transplants fail if patients get too weak. New program tries inpatient prehab First Opinion August 3, 2026 I’m a neurologist. I’ve delivered ALS diagnoses.

Then I received one myself Advertisement First Opinion August 3, 2026 We lead the Federation of State Medical Boards. Here’s what we think about licensing AI to practice medicine In the Lab August 2, 2026 STAT Plus: Senate measure would block Trump plan to politicize federal grants, for now Pharmalot August 2, 2026 STAT Plus: Michigan Supreme Court ruling allows probe into Lilly insulin pricing Subscriber Picks

source

Reporting by STAT.

read at STAT ↗
475 words · retrieved 6h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.2LILLY
drugs
Rare Disease2insulin
topics
Rare Disease2ALSCardiology

related stories

  • 5d agoGSK cost-cutting plan includes global layoffsBioSpace
  • Jul 24STAT+: Fatal gene-editing trial in China raises ethics and oversight questionsSTAT
  • Jul 23FDA panel confronting peptide controversySTAT
  • Jul 22Royalty Pharma pens $425M deal for slice of sales on AstraZeneca’s ATTR drugFierce Biotech
  • Jul 10STAT+: Roche ends Huntington’s gene-silencing programsSTAT